LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 Seliciclib
10
uM
LJP5
 0.4149 0.0121 0.1970 0.0256
BT-20 AT-7519
0.04
uM
LJP6
 0.9099 0.0431 0.8910 0.0507
BT-20 AT-7519
0.12
uM
LJP6
 0.7631 0.1361 0.6951 0.1791
BT-20 AT-7519
0.37
uM
LJP6
 0.4490 0.1643 0.2072 0.2503
BT-20 AT-7519
1.11
uM
LJP6
 0.2171 0.0328 -0.2067 0.0710
BT-20 AT-7519
3.33
uM
LJP6
 0.1541 0.0396 -0.3612 0.1193
BT-20 AT-7519
10
uM
LJP6
 0.1295 0.0294 -0.4221 0.1050
BT-20 AZD7762
0.04
uM
LJP6
 1.0457 0.0268 1.0539 0.0311
BT-20 AZD7762
0.12
uM
LJP6
 0.8979 0.0652 0.8737 0.0790
BT-20 AZD7762
0.37
uM
LJP6
 0.7146 0.0698 0.6337 0.0887
BT-20 AZD7762
1.11
uM
LJP6
 0.4665 0.0633 0.2622 0.0860
BT-20 AZD7762
3.33
uM
LJP6
 0.2866 0.0469 -0.0616 0.0718
BT-20 AZD7762
10
uM
LJP6
 0.1286 0.0143 -0.4183 0.0570
BT-20 AZD8055
0.04
uM
LJP6
 0.4900 0.0626 0.2999 0.0820
BT-20 AZD8055
0.12
uM
LJP6
 0.4167 0.0521 0.1787 0.0725
BT-20 AZD8055
0.37
uM
LJP6
 0.3603 0.0304 0.0816 0.0361
BT-20 AZD8055
1.11
uM
LJP6
 0.3462 0.0305 0.0556 0.0412
BT-20 AZD8055
3.33
uM
LJP6
 0.3135 0.0337 -0.0065 0.0495
BT-20 AZD8055
10
uM
LJP6
 0.1935 0.0805 -0.3059 0.2085
BT-20 Sorafenib
0.04
uM
LJP6
 0.9473 0.0098 0.9357 0.0099
BT-20 Sorafenib
0.12
uM
LJP6
 0.9431 0.0116 0.9308 0.0135
BT-20 Sorafenib
0.37
uM
LJP6
 0.8825 0.0265 0.8555 0.0299
BT-20 Sorafenib
1.11
uM
LJP6
 0.8768 0.0201 0.8492 0.0210
BT-20 Sorafenib
3.33
uM
LJP6
 0.8666 0.0156 0.8358 0.0150
BT-20 Sorafenib
10
uM
LJP6
 0.5798 0.1450 0.4288 0.2023